πŸ‡ΊπŸ‡Έ FDA
Patent

US 7547509

Cyanovirin variant-polymer conjugates

granted A61PA61P31/12A61P31/14

Quick answer

US patent 7547509 (Cyanovirin variant-polymer conjugates) held by Nektar Therapeutics AL, Corporation expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics AL, Corporation
Grant date
Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P31/12, A61P31/14, A61P31/16, A61P31/18